Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

72
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
72
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

46
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
46
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. Stemi患者における皮膚経冠動脈介入後の調整された血動脈指数と主要な不良心疾患との関連:中国での予見的観察研究

STEMI患者における皮膚経冠動脈介入後の調整された血動脈指数と主要な不良心疾患との関連:中国での予見的観察研究

Dong Wu1, Xiaowu Wang2, Zhenfeng Yang1

  • 1Department of Pharmacy, Fuyang People's Hospital, Fuyang, China.

BMJ open
|August 21, 2025

関連する実験動画

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.4K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.6K

PubMed で要約を見る

まとめ
この要約は機械生成です。

調整された血動脈指数 (aAIP) の上昇は,ST上昇性心筋梗塞 (STEMI) の患者における皮膚経冠動脈介入 (PCI) の後の主要な心血管疾患 (MACE) のリスクおよび再入院の増加と関連しています. この発見はリスクの階層化のための 潜在的なバイオマーカーを強調しています

科学分野:

  • 心血管医学
  • バイオマーカー
  • 介入心臓科

背景:

  • 血動脈性指数 (AIP) は,心血管疾患 (CVD) リスクの認識されたバイオマーカーです.
  • STセグメント上昇性心筋梗塞 (STEMI) の患者における皮膚穿越性冠動脈干渉 (PCI) の後のAIPと主要な心血管疾患 (MACE) の関連性に関する研究は限られている.

研究 の 目的:

  • PCI を受けているSTEMI患者における調整された血性指数 (aAIP) とMACEとの関係を調査する.
  • すべての原因による死亡率と再入院率を含む二次結果とAIPの関連性を評価する.

主な方法:

  • PCIを受けた334人のSTEMI患者を対象とした前向きな観察研究.
  • aAIPの計算は,aAIP=log ((トリグリセリド/高密度リポタンパク質コレステロール × 100) という式を用いて行う.
  • 患者はAIP四分位数に基づいて4つの層に分けられ,MACEおよび他のエンドポイントが分析された.

主要な成果:

  • 多変量モデルでは,より高い連続的なaAIPとMACEが正に相関していた.
  • aAIPの最高四分位 (Q3とQ4) に属する患者は,最低四分位 (Q1) に比べて,著しく高いMACEリスクを示した.
  • 増加したAIP (Q4対Q1) は,全因死亡率および全因/無計画再入院のリスクの増加と関連していました.
キーワード:
冠動脈の介入心臓 の 原因 で の 突然 の 死心筋梗塞

関連する実験動画

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.4K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.6K

結論:

  • 高いaAIPは,PCI後のSTEMI患者における増加したMACE,すべての原因による再入院,および計画外再入院の有意な予測因子である.
  • この結果から,aAIPは,この患者集団におけるリスク層分化の重要なバイオマーカーとして機能することが示唆される.